Abstract

The aim of this cross-sectional study was to examine the association between the geriatric nutritional risk index (GNRI) and the prevalence of sarcopenia in people with type 2 diabetes (T2DM). Having both low handgrip strength (<28 kg for men and <18 kg for women) and low skeletal muscle mass index (<7.0 kg/m2 for men and <5.7 kg/m2 for women) was diagnosed as sarcopenia. GNRI was estimated by the formula as below: GNRI = (1.489 × serum albumin level [g/L]) + (41.7 × [current body weight (kg)/ideal body weight (kg)]). Participants were dichotomized on the basis of their GNRI scores (GNRI < 98, low; or GNRI ≥ 98, high). Among 526 people (301 men and 225 women) with T2DM, the proportions of participants with sarcopenia and low GNRI were 12.7% (n = 67/526) and 5.1% (n = 27/526), respectively. The proportion of sarcopenia in participants with low-GNRI was higher than that with high GNRI (44.4% [n = 12/27] vs. 11.0% [n = 55/499], p < 0.001). The GNRI showed positive correlations with handgrip strength (r = 0.232, p < 0.001) and skeletal muscle mass index (r = 0.514, p < 0.001). Moreover, low GNRI was related to the prevalence of sarcopenia (adjusted odds ratio, 4.88 [95% confidence interval: 1.88–12.7], p = 0.001). The GNRI, as a continuous variable, was also related to the prevalence of sarcopenia (adjusted odds ratio, 0.89 [95% confidence interval: 0.86–0.93], p < 0.001). The present study revealed that low GNRI was related to the prevalence of sarcopenia.

Highlights

  • The population of people with type 2 diabetes mellitus (T2DM) is globally on the rise [1]

  • 560 individuals with T2DM were assessed for body composition and enrolled in this study

  • We initially examined the relationship between the geriatric nutritional risk index (GNRI) and the prevalence of sarcopenia in people with T2DM

Read more

Summary

Introduction

The population of people with type 2 diabetes mellitus (T2DM) is globally on the rise [1]. Sarcopenia is a potentially greater public health concern [2], with the aging population. The Asian Working Group for Sarcopenia states that the characteristics of sarcopenia are low muscle strength, muscle mass loss, and low physical performance [2]. The mechanisms underlying the muscle mass loss differ between healthy individuals and people with diabetes. Muscle catabolism is enhanced in individuals with T2DM due to insulin resistance and attenuated insulin signaling [3]. T2DM has been related to a 1.55-fold higher risk of sarcopenia in older adults than in the general population [4]. Sarcopenia in people with T2DM requires more attention than those without diabetes

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.